Adverse effects following the inadvertent administration of opioids to infants and children

Clinical Pediatrics

Volumn 44, Issue 6, 2005, Pages 499-503

  Meyer, David ^a   Tobias, Joseph D ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; FENTANYL; HYDROCODONE BITARTRATE PLUS PARACETAMOL; METHADONE; OPIATE DERIVATIVE; PARACETAMOL;

ARTICLE; BREAST FEEDING; CASE REPORT; CONSTIPATION; DYSPHORIA; FEMALE; HUMAN; HYPOTENSION; INFANT; MENTAL DISEASE; NAUSEA; OPIOID INDUCED EMESIS; PAIN; PHYSICAL EXAMINATION; PLASMA; PRESCHOOL CHILD; PRURITUS; RESPIRATION DEPRESSION; RISK ASSESSMENT; SCREENING; SIDE EFFECT; SYMPTOMATOLOGY; URINALYSIS; URINE RETENTION; WITHDRAWAL SYNDROME;

CHILD; CODEINE; FEMALE; FENTANYL; HALF-LIFE; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; MILK, HUMAN; NARCOTICS;

EID: 22044437115     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280504400605     Document Type: Article

References (22)

1. Williams DG, Patel A, Howard RF. Pharmacogenetics ol codeine metabolism in an urban population of children and its implications fur analgesic reliability. Br J Anaesth. 2002;89:839-845.
2. Dale O, Sheffels P, Kharasch ED. Bioavailabilities of rectal and oral methadone in healthy subjects. Br J Clin Pharmacol. 2004;58:156-162.
3. McCarthy JJ, Posey BL. Methadone levels in human milk. J Hum Lact. 2000;16:115-120.
4. Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108:776-789.
5. Smialek JE, Monforte JR, Aronow R, Spitz WU. Methadone deaths in children: a continuing problem. JAMA. 1977;238:2516-2517.
6. Atkinson HC, Begg EJ, Darlow BA. Drugs in human milk: clinical pharmacokinetic considerations. Clin Pharmacokinet. 1988;14:217-240.
7. Howard CR, Lawrence RA. Drugs and breastfeeding. Clin Perinatology. 1999;26:447-478.
8. Way WL, Costley EC, Way EL. Respiratory sensitivity of the newborn infant to meperidine and morphine. Clin Pharmacol Ther. 1965;6:454-461.
9. Lynn AM, Slattery JT. Morphine pharmacokinetics in early infancy. Anesthesiology. 1987;66:136-139.
10. Osbourne R, Joel S, Trew D, Slevin M. Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther. 1990;47:12-19.
11. Chay PC, Duffy BJ, Walker JS. Pharmacokinetic-pharmacodynamic relationships of morphine in neonates. Clin Pharmacol Ther. 1992;51:334-342.
12. Choonara IA, McKay P, Hain R, Rane A. Morphine metabolism in children. Br J Clin Pharmacol. 1989;28:599-604.
13. Lynn AM, Nespeca MK, Opheim KE, et al. Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery. Anesth Analg. 1993; 77:695-701.
14. Olkkola KT, Maunuksela EL, Korpela R, et al. Kinetics and dynamics of postoperative morphine in children. Clin Pharmacol Ther. 1988;44:128-136.
15. Nichols DG, Vaster M, Lynn AM, et al. Disposition and respiratory effects of intrathecal morphine in children. Anesthesiology. 1993;79:733-738.
16. Maio RF, Gaukel B, Freeman B. Intralingual naloxone injection for narcotic-induced respiratory depression. Ann Emerg Med. 1987;16:572-573.
17. Wasiak J, Clavisi O. Is subcutaneous or intramuscular naloxone as effective as intravenous naloxone in the treatment of life-threatening heroin overdose? Med J Australia. 2002;176:495-496.
18. Tandberg D, Abercrombie D. Treatment of heroin overdose with endotracheal naloxone. Ann Emerg Med. 1982;11:448-445.
19. Barton KD, Ramos J, Coldwell C, et al. Intranasal administration of naloxone by paramedics. Prehospital Emergency Care. 2002;6:54-58.
20. Lewis JM, Klein-Schwartz W, Benson BE, et al. Continuous naloxone infusion in pediatric narcotic overdose. Am J Dis Child. 1984;138:944-946.
21. Kaplan JL, Marx JA, Calabro JJ, et al. Double-blind, randomized study of nalmefene and naloxone in emergency department patients with suspected narcotic overdose. Ann Emerg Med. 1999;34:42-50.
22. Gonzalez JP, Brogden RN. Naltrexone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs. 1988;35:192-213.